TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
WP254	Apoptosis	0.000699089986830546	-7.26573108749191	86	7	0.0752688172043011	93	5314	54205,1677,842,3480,9169,8738,841	CYCS,DFFB,CASP9,IGF1R,SCAF11,CRADD,CASP8
WP384	Apoptosis Modulation by HSP70	0.00410412609288853	-5.49576244719761	19	3	0.032258064516129	93	5314	841,842,54205	CASP8,CASP9,CYCS
WP1422	Sphingolipid Metabolism	0.00476773529442269	-5.34588386786956	20	3	0.032258064516129	93	5314	253782,91012,204219	CERS6,CERS5,CERS3
WP2507	Nanomaterial induced apoptosis	0.0054925437326714	-5.20436379148479	21	3	0.032258064516129	93	5314	54205,842,841	CYCS,CASP9,CASP8
WP314	Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation	0.00699202775124945	-4.96298467163657	44	4	0.043010752688172	93	5314	842,1677,54205,841	CASP9,DFFB,CYCS,CASP8
WP2276	Glial Cell Differentiation	0.00792200469126004	-4.83811098760131	8	2	0.021505376344086	93	5314	11076,4478	TPPP,MSN
WP1772	Apoptosis Modulation and Signaling	0.0238377333616842	-3.73648551841566	94	5	0.0537634408602151	93	5314	841,8738,1677,54205,842	CASP8,CRADD,DFFB,CYCS,CASP9
WP2324	AGE/RAGE pathway	0.0277771065424015	-3.58354310322162	66	4	0.043010752688172	93	5314	4478,842,54205,841	MSN,CASP9,CYCS,CASP8
WP2011	SREBF and miR33 in cholesterol and lipid homeostasis	0.0427174307340689	-3.15314822813157	19	2	0.021505376344086	93	5314	6319,6721	SCD,SREBF2
WP2267	Synaptic Vesicle Pathway	0.0620098634197452	-2.78046181917486	52	3	0.032258064516129	93	5314	6532,6854,100500912	SLC6A4,SYN2,MIR3674
WP1981	Thyroxine (Thyroid Hormone) Production	0.100562465696361	-2.2969761953472	6	1	0.010752688172043	93	5314	7038	TG
WP474	Endochondral Ossification	0.104544379619543	-2.2581436123761	65	3	0.032258064516129	93	5314	657,2690,3480	BMPR1A,GHR,IGF1R
WP707	DNA Damage Response	0.119459868856775	-2.12477478947889	69	3	0.032258064516129	93	5314	841,842,54205	CASP8,CASP9,CYCS
WP2359	Parkin-Ubiquitin Proteasomal System pathway	0.12330722925162	-2.09307623913059	70	3	0.032258064516129	93	5314	5071,10382,841	PARK2,TUBB4A,CASP8
WP306	Focal Adhesion	0.125436029131358	-2.07595937840278	195	6	0.0645161290322581	93	5314	3480,394,1290,29780,859,3918	IGF1R,ARHGAP5,COL5A2,PARVB,CAV3,LAMC2
WP1984	Integrated Breast Cancer Pathway	0.131741501574061	-2.02691359782285	154	5	0.0537634408602151	93	5314	657,841,8438,842,6597	BMPR1A,CASP8,RAD54L,CASP9,SMARCA4
WP1982	Sterol Regulatory Element-Binding Proteins (SREBP) signalling	0.135115966827316	-2.00162185574901	73	3	0.032258064516129	93	5314	51128,6721,6319	SAR1B,SREBF2,SCD
WP2857	Mesodermal Commitment Pathway	0.13698825541613	-1.98786008371833	156	5	0.0537634408602151	93	5314	26610,58499,657,29072,3172	ELP4,ZNF462,BMPR1A,SETD2,HNF4A
WP3593	miR-148a/miR-31/FIH1/HIF1&alpha;-Notch signaling in glioblastoma	0.147023975534124	-1.91715960663099	9	1	0.010752688172043	93	5314	55662	HIF1AN
WP1433	Nucleotide-binding Oligomerization Domain (NOD) pathway	0.160622592936015	-1.82869780905729	41	2	0.021505376344086	93	5314	842,841	CASP9,CASP8
WP2874	Liver X Receptor Pathway	0.161977183880161	-1.82029979391459	10	1	0.010752688172043	93	5314	6319	SCD
WP3656	Interleukin-1 Induced Activation of NF-kappa-B	0.161977183880161	-1.82029979391459	10	1	0.010752688172043	93	5314	7334	UBE2N
WP1455	Serotonin Transporter Activity	0.17667102285056	-1.7334659037634	11	1	0.010752688172043	93	5314	6532	SLC6A4
WP2513	Nanoparticle triggered regulated necrosis	0.17667102285056	-1.7334659037634	11	1	0.010752688172043	93	5314	841	CASP8
WP2371	Parkinsons Disease Pathway	0.17702811709549	-1.73144670537738	83	3	0.032258064516129	93	5314	54205,5071,842	CYCS,PARK2,CASP9
WP2007	Iron metabolism in placenta	0.191109943246953	-1.65490639744664	12	1	0.010752688172043	93	5314	7037	TFRC
WP1425	Bone Morphogenic Protein (BMP) Signalling and Regulation	0.191109943246953	-1.65490639744664	12	1	0.010752688172043	93	5314	657	BMPR1A
WP1971	Integrated Cancer Pathway	0.192050044470813	-1.64999929263174	46	2	0.021505376344086	93	5314	842,841	CASP9,CASP8
WP1423	Ganglio Sphingolipid Metabolism	0.205298320328612	-1.58329113653669	13	1	0.010752688172043	93	5314	2523	FUT1
WP1530	miRNA Regulation of DNA Damage Response	0.222014753419086	-1.50501144247529	93	3	0.032258064516129	93	5314	54205,842,841	CYCS,CASP9,CASP8
WP231	TNF alpha Signaling Pathway	0.226641085900077	-1.48438763217204	94	3	0.032258064516129	93	5314	842,283455,841	CASP9,KSR2,CASP8
WP47	Hedgehog Signaling Pathway	0.246402837407598	-1.40078753193616	16	1	0.010752688172043	93	5314	51684	SUFU
WP12	Osteoclast Signaling	0.246402837407598	-1.40078753193616	16	1	0.010752688172043	93	5314	3454	IFNAR1
WP1946	Cori Cycle	0.246402837407598	-1.40078753193616	16	1	0.010752688172043	93	5314	2821	GPI
WP2272	Pathogenic Escherichia coli infection	0.250226362163835	-1.38538932213591	55	2	0.021505376344086	93	5314	100506658,10382	OCLN,TUBB4A
WP3678	Amplification and Expansion of Oncogenic Pathways as Metastatic Traits	0.259631326668785	-1.34849262859443	17	1	0.010752688172043	93	5314	7428	VHL
WP3874	Canonical and Non-Canonical TGF-B signaling	0.259631326668785	-1.34849262859443	17	1	0.010752688172043	93	5314	657	BMPR1A
WP3664	Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds	0.272630059278983	-1.29963949698381	18	1	0.010752688172043	93	5314	1856	DVL2
WP615	Senescence and Autophagy in Cancer	0.283365281482669	-1.26101846634848	106	3	0.032258064516129	93	5314	3480,3621,6678	IGF1R,ING1,SPARC
WP404	Nucleotide Metabolism	0.285402983087478	-1.25385312169032	19	1	0.010752688172043	93	5314	158	ADSL
WP697	Estrogen metabolism	0.285402983087478	-1.25385312169032	19	1	0.010752688172043	93	5314	412	STS
WP2879	Farnesoid X Receptor  Pathway	0.285402983087478	-1.25385312169032	19	1	0.010752688172043	93	5314	1582	CYP8B1
WP3877	Simplified Depiction of MYD88 Distinct Input-Output Pathway	0.285402983087478	-1.25385312169032	19	1	0.010752688172043	93	5314	7334	UBE2N
WP706	Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways	0.314902610021162	-1.1554918624968	162	4	0.043010752688172	93	5314	859,6532,11076,4010	CAV3,SLC6A4,TPPP,LMX1B
WP3651	Pathways Affected in Adenoid Cystic Carcinoma	0.321878414792326	-1.13358139855688	66	2	0.021505376344086	93	5314	51742,29072	ARID4B,SETD2
WP3657	Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex	0.322405380511449	-1.13194557955763	22	1	0.010752688172043	93	5314	6597	SMARCA4
WP357	Fatty Acid Biosynthesis	0.322405380511449	-1.13194557955763	22	1	0.010752688172043	93	5314	6319	SCD
WP1424	Globo Sphingolipid Metabolism	0.322405380511449	-1.13194557955763	22	1	0.010752688172043	93	5314	2523	FUT1
WP1403	AMP-activated Protein Kinase (AMPK) Signaling	0.334783989512292	-1.09426976256078	68	2	0.021505376344086	93	5314	3172,3953	HNF4A,LEPR
WP698	Glucuronidation	0.368808612312623	-0.997477435314703	26	1	0.010752688172043	93	5314	54577	UGT1A7
WP2878	PPAR Alpha Pathway	0.368808612312623	-0.997477435314703	26	1	0.010752688172043	93	5314	1582	CYP8B1
WP2361	Gastric Cancer Network 1	0.390816958637364	-0.939515965084193	28	1	0.010752688172043	93	5314	54476	RNF216
WP3613	Photodynamic therapy-induced unfolded protein response	0.401534707946552	-0.912461303636512	29	1	0.010752688172043	93	5314	9695	EDEM1
WP2583	T-Cell Receptor and Co-stimulatory Signaling	0.401534707946552	-0.912461303636512	29	1	0.010752688172043	93	5314	5133	PDCD1
WP2328	Allograft Rejection	0.410420989232423	-0.890571843079496	80	2	0.021505376344086	93	5314	841,842	CASP8,CASP9
WP2855	Dopaminergic Neurogenesis	0.412065885268954	-0.88657202671642	30	1	0.010752688172043	93	5314	4010	LMX1B
WP3851	TLR4 Signaling and Tolerance	0.412065885268954	-0.88657202671642	30	1	0.010752688172043	93	5314	3635	INPP5D
WP3850	Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling	0.422413703714303	-0.861770104610881	31	1	0.010752688172043	93	5314	3480	IGF1R
WP34	Ovarian Infertility Genes	0.432581321648822	-0.837984943351358	32	1	0.010752688172043	93	5314	23224	SYNE2
WP727	Monoamine Transport	0.432581321648822	-0.837984943351358	32	1	0.010752688172043	93	5314	6532	SLC6A4
WP453	Inflammatory Response Pathway	0.442571843627617	-0.815152469232373	33	1	0.010752688172043	93	5314	3918	LAMC2
WP2377	Integrated Pancreatic Cancer Pathway	0.454671016235111	-0.788181162793087	197	4	0.043010752688172	93	5314	841,1677,3172,842	CASP8,DFFB,HNF4A,CASP9
WP2858	Ectoderm Differentiation	0.459709371226986	-0.77716079085025	143	3	0.032258064516129	93	5314	2720,657,23229	GLB1,BMPR1A,ARHGEF9
WP244	Alpha 6 Beta 4 signaling pathway	0.462033754275335	-0.772117329367213	35	1	0.010752688172043	93	5314	3918	LAMC2
WP299	Nuclear Receptors in Lipid Metabolism and Toxicity	0.462033754275335	-0.772117329367213	35	1	0.010752688172043	93	5314	1582	CYP8B1
WP1449	Regulation of toll-like receptor signaling pathway	0.46885868209825	-0.757453873428834	145	3	0.032258064516129	93	5314	841,3454,54476	CASP8,IFNAR1,RNF216
WP2853	Endoderm Differentiation	0.46885868209825	-0.757453873428834	145	3	0.032258064516129	93	5314	26610,58499,657	ELP4,ZNF462,BMPR1A
WP500	Glycogen Metabolism	0.471511091053043	-0.751812654273209	36	1	0.010752688172043	93	5314	5261	PHKG2
WP1471	Target Of Rapamycin (TOR) Signaling	0.480823229840292	-0.732255581952621	37	1	0.010752688172043	93	5314	79899	PRR5L
WP619	Type II interferon signaling (IFNG)	0.480823229840292	-0.732255581952621	37	1	0.010752688172043	93	5314	8370	HIST2H4A
WP3614	Photodynamic therapy-induced HIF-1 survival signaling	0.480823229840292	-0.732255581952621	37	1	0.010752688172043	93	5314	55662	HIF1AN
WP2059	Alzheimers Disease	0.48245604698534	-0.728865456683339	148	3	0.032258064516129	93	5314	841,54205,842	CASP8,CYCS,CASP9
WP383	Striated Muscle Contraction	0.489973019421575	-0.713404951798404	38	1	0.010752688172043	93	5314	7135	TNNI1
WP2447	Amyotrophic lateral sclerosis (ALS)	0.489973019421575	-0.713404951798404	38	1	0.010752688172043	93	5314	842	CASP9
WP536	Calcium Regulation in the Cardiac Cell	0.495892492302997	-0.701396125139873	151	3	0.032258064516129	93	5314	486,818,112	FXYD2,CAMK2G,ADCY6
WP170	Nuclear Receptors	0.498963259984954	-0.695222813225901	39	1	0.010752688172043	93	5314	3172	HNF4A
WP35	G Protein Signaling Pathways	0.504335928347262	-0.684512708441033	96	2	0.021505376344086	93	5314	102465803,112	MIR7706,ADCY6
WP2516	ATM Signaling Pathway	0.5077967039284	-0.677674100618013	40	1	0.010752688172043	93	5314	8738	CRADD
WP524	G13 Signaling Pathway	0.5077967039284	-0.677674100618013	40	1	0.010752688172043	93	5314	57630	SH3RF1
WP2036	TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway	0.525003977568786	-0.644349440097717	42	1	0.010752688172043	93	5314	841	CASP8
WP2911	miRNA targets in ECM and membrane receptors	0.53338308039909	-0.628515388023992	43	1	0.010752688172043	93	5314	1290	COL5A2
WP1544	MicroRNAs in cardiomyocyte hypertrophy	0.537039938601487	-0.621682813679282	102	2	0.021505376344086	93	5314	5592,3480	PRKG1,IGF1R
WP716	Vitamin A and Carotenoid Metabolism	0.541615934411565	-0.613198136820619	44	1	0.010752688172043	93	5314	195814	SDR16C5
WP75	Toll-like Receptor Signaling Pathway	0.542347301344817	-0.611848705363703	103	2	0.021505376344086	93	5314	841,3454	CASP8,IFNAR1
WP179	Cell Cycle	0.552837166527323	-0.592691775562746	105	2	0.021505376344086	93	5314	8556,84515	CDC14A,MCM8
WP1591	Heart Development	0.557652954324642	-0.584018455744019	46	1	0.010752688172043	93	5314	657	BMPR1A
WP268	Notch Signaling Pathway	0.557652954324642	-0.584018455744019	46	1	0.010752688172043	93	5314	1856	DVL2
WP3878	ATM Signaling Network in Development and Disease	0.557652954324642	-0.584018455744019	46	1	0.010752688172043	93	5314	64421	DCLRE1C
WP2873	Aryl Hydrocarbon Receptor Pathway	0.573134726915926	-0.556634464397343	48	1	0.010752688172043	93	5314	54577	UGT1A7
WP382	MAPK Signaling Pathway	0.576718993643205	-0.550400143853342	170	3	0.032258064516129	93	5314	51776,841,842	MAP3K20,CASP8,CASP9
WP286	IL-3 Signaling Pathway	0.580673365428043	-0.54356687397591	49	1	0.010752688172043	93	5314	3635	INPP5D
WP534	Glycolysis and Gluconeogenesis	0.580673365428043	-0.54356687397591	49	1	0.010752688172043	93	5314	2821	GPI
WP3646	Hepatitis C and Hepatocellular Carcinoma	0.595357731795261	-0.518592824194796	51	1	0.010752688172043	93	5314	842	CASP9
WP107	Translation Factors	0.609533204819709	-0.495061852759314	53	1	0.010752688172043	93	5314	1979	EIF4EBP2
WP363	Wnt Signaling Pathway Netpath	0.609533204819709	-0.495061852759314	53	1	0.010752688172043	93	5314	1856	DVL2
WP623	Oxidative phosphorylation	0.616435583056203	-0.483801449985905	54	1	0.010752688172043	93	5314	498	ATP5A1
WP3286	Copper homeostasis	0.616435583056203	-0.483801449985905	54	1	0.010752688172043	93	5314	538	ATP7A
WP673	ErbB Signaling Pathway	0.616435583056203	-0.483801449985905	54	1	0.010752688172043	93	5314	10718	NRG3
WP585	Interferon type I signaling pathways	0.623217235298658	-0.472860128680522	55	1	0.010752688172043	93	5314	3454	IFNAR1
WP395	IL-4 Signaling Pathway	0.623217235298658	-0.472860128680522	55	1	0.010752688172043	93	5314	3635	INPP5D
WP2795	Cardiac Hypertrophic Response	0.636426682006413	-0.451886056925974	57	1	0.010752688172043	93	5314	5592	PRKG1
WP195	IL-1 signaling pathway	0.636426682006413	-0.451886056925974	57	1	0.010752688172043	93	5314	7334	UBE2N
WP3527	Preimplantation Embryo	0.655386482634555	-0.422530167534087	60	1	0.010752688172043	93	5314	6597	SMARCA4
WP304	Kit receptor signaling pathway	0.655386482634555	-0.422530167534087	60	1	0.010752688172043	93	5314	3635	INPP5D
WP3865	RIG-I-like Receptor Signaling	0.661486417369268	-0.413265828715382	61	1	0.010752688172043	93	5314	841	CASP8
WP3863	T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection	0.667479519064158	-0.404246572228417	62	1	0.010752688172043	93	5314	5133	PDCD1
WP43	Oxidation by Cytochrome P450	0.673367638775661	-0.395463829876112	63	1	0.010752688172043	93	5314	1582	CYP8B1
WP236	Adipogenesis	0.673790896668481	-0.394835458536569	131	2	0.021505376344086	93	5314	8609,6319	KLF7,SCD
WP3915	Angiopoietin Like Protein 8 Regulatory Pathway	0.677874692518556	-0.388792827417096	132	2	0.021505376344086	93	5314	6721,6319	SREBF2,SCD
WP183	Proteasome Degradation	0.690420144034453	-0.370454962300138	66	1	0.010752688172043	93	5314	5683	PSMA2
WP2032	Human Thyroid Stimulating Hormone (TSH) signaling pathway	0.7012961040255	-0.354825078815462	68	1	0.010752688172043	93	5314	3480	IGF1R
WP3303	Rac1/Pak1/p38/MMP-2 pathway	0.7012961040255	-0.354825078815462	68	1	0.010752688172043	93	5314	842	CASP9
WP3680	Association Between Physico-Chemical Features and Toxicity Associated Pathways	0.7012961040255	-0.354825078815462	68	1	0.010752688172043	93	5314	5217	PFN2
WP176	Folate Metabolism	0.706591464743833	-0.347302623462296	69	1	0.010752688172043	93	5314	113235	SLC46A1
WP2369	Histone Modifications	0.706591464743833	-0.347302623462296	69	1	0.010752688172043	93	5314	29072	SETD2
WP428	Wnt Signaling Pathway	0.711793942104452	-0.339966816613163	70	1	0.010752688172043	93	5314	1856	DVL2
WP2884	NRF2 pathway	0.720125082153335	-0.328330356847548	143	2	0.021505376344086	93	5314	54577,6532	UGT1A7,SLC6A4
WP24	Peptide GPCRs	0.731706842225352	-0.312375334001048	74	1	0.010752688172043	93	5314	4985	OPRD1
WP2572	Primary Focal Segmental Glomerulosclerosis FSGS	0.731706842225352	-0.312375334001048	74	1	0.010752688172043	93	5314	4010	LMX1B
WP2034	Leptin signaling pathway	0.74114660713426	-0.299556822872239	76	1	0.010752688172043	93	5314	3953	LEPR
WP2118	Arrhythmogenic Right Ventricular Cardiomyopathy	0.74114660713426	-0.299556822872239	76	1	0.010752688172043	93	5314	785	CACNB4
WP51	Regulation of Actin Cytoskeleton	0.741169435131632	-0.299526022426554	149	2	0.021505376344086	93	5314	8396,4478	PIP4K2B,MSN
WP289	Myometrial Relaxation and Contraction Pathways	0.770224458249458	-0.261073302393432	158	2	0.021505376344086	93	5314	112,818	ADCY6,CAMK2G
WP2261	Signaling Pathways in Glioblastoma	0.771670746013725	-0.25919731473301	83	1	0.010752688172043	93	5314	3480	IGF1R
WP481	Insulin Signaling	0.779267511349326	-0.249400888531584	161	2	0.021505376344086	93	5314	4641,3480	MYO1C,IGF1R
WP437	EGF/EGFR Signaling Pathway	0.782212849078169	-0.245628389950629	162	2	0.021505376344086	93	5314	10617,3635	STAMBP,INPP5D
WP3925	Amino Acid metabolism	0.802214486522354	-0.220379267317148	91	1	0.010752688172043	93	5314	57818	G6PC2
WP2355	Corticotropin-releasing hormone signaling pathway	0.809195923103953	-0.211714211882216	93	1	0.010752688172043	93	5314	842	CASP9
WP111	Electron Transport Chain	0.809195923103953	-0.211714211882216	93	1	0.010752688172043	93	5314	498	ATP5A1
WP702	Metapathway biotransformation	0.8248949668074	-0.192499213713166	178	2	0.021505376344086	93	5314	1582,54577	CYP8B1,UGT1A7
WP23	B Cell Receptor Signaling Pathway	0.825600927050879	-0.191643761374075	98	1	0.010752688172043	93	5314	3635	INPP5D
WP2064	Neural Crest Differentiation	0.837713575638164	-0.177079032106529	102	1	0.010752688172043	93	5314	1856	DVL2
WP185	Integrin-mediated Cell Adhesion	0.840609323428752	-0.173628265075113	103	1	0.010752688172043	93	5314	859	CAV3
WP399	Wnt Signaling Pathway and Pluripotency	0.848993377311336	-0.16370389327679	106	1	0.010752688172043	93	5314	1856	DVL2
WP710	DNA Damage Response (only ATM dependent)	0.869277362948757	-0.140093029787477	114	1	0.010752688172043	93	5314	1856	DVL2
WP411	mRNA Processing	0.905584601231104	-0.0991745756187064	132	1	0.010752688172043	93	5314	3181	HNRNPA2B1
WP2380	Brain-Derived Neurotrophic Factor (BDNF) signaling pathway	0.924043996911877	-0.0789955927685501	144	1	0.010752688172043	93	5314	6792	CDKL5
WP455	GPCRs, Class A Rhodopsin-like	0.94615617473512	-0.0553476339840344	259	2	0.021505376344086	93	5314	81491,4985	GPR63,OPRD1
WP3594	Circadian rythm related genes	0.975963051862303	-0.0243305499840872	207	1	0.010752688172043	93	5314	6532	SLC6A4
WP2289	Drug Induction of Bile Acid Pathway	0.999999999987941	-1.20594192527245e-11	17	0	0	93	5314
WP78	TCA Cycle	0.999999999987941	-1.20594192527245e-11	17	0	0	93	5314
WP2916	Interactome of polycomb repressive complex 2 (PRC2)	0.999999999987941	-1.20594192527245e-11	17	0	0	93	5314
WP368	Mitochondrial LC-Fatty Acid Beta-Oxidation	0.999999999987941	-1.20594192527245e-11	17	0	0	93	5314
WP554	ACE Inhibitor Pathway	0.999999999987941	-1.20594192527245e-11	17	0	0	93	5314
WP262	EBV LMP1 signaling	0.999999999991017	-8.98289160970191e-12	24	0	0	93	5314
WP1539	Angiogenesis	0.999999999991017	-8.98289160970191e-12	24	0	0	93	5314
WP3658	Wnt/beta-catenin Signaling Pathway in Leukemia	0.999999999991017	-8.98289160970191e-12	24	0	0	93	5314
WP2509	Nanoparticle triggered autophagic cell death	0.999999999991017	-8.98289160970191e-12	24	0	0	93	5314
WP334	GPCRs, Class B Secretin-like	0.999999999991017	-8.98289160970191e-12	24	0	0	93	5314
WP3679	Cell-type Dependent Selectivity of CCK2R Signaling	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP3871	Valproic acid pathway	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP1434	Osteopontin Signaling	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP2881	Estrogen Receptor Pathway	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP1991	SRF and miRs in Smooth Muscle Differentiation and Proliferation	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP3876	BMP2-WNT4-FOXO1 Pathway in Human Primary Endometrial Stromal Cell Differentiation	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP186	Homologous recombination	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP3892	Development of pulmonary dendritic cells and macrophage subsets	0.999999999991223	-8.776694599903e-12	13	0	0	93	5314
WP2290	RalA downstream regulated genes	0.999999999991442	-8.55820730151722e-12	12	0	0	93	5314
WP106	Alanine and aspartate metabolism	0.999999999991442	-8.55820730151722e-12	12	0	0	93	5314
WP3301	MFAP5-mediated ovarian cancer cell motility and invasiveness	0.999999999991442	-8.55820730151722e-12	12	0	0	93	5314
WP1559	TFs Regulate miRNAs related to cardiac hypertrophy	0.999999999991442	-8.55820730151722e-12	12	0	0	93	5314
WP3849	MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ	0.999999999991442	-8.55820730151722e-12	12	0	0	93	5314
WP3672	LncRNA-mediated mechanisms of therapeutic resistance	0.999999999991442	-8.55820730151722e-12	12	0	0	93	5314
WP2525	Trans-sulfuration and one carbon metabolism	0.999999999992357	-7.64305478596649e-12	32	0	0	93	5314
WP2875	Constitutive Androstane Receptor Pathway	0.999999999992357	-7.64305478596649e-12	32	0	0	93	5314
WP2828	Bladder Cancer	0.999999999992357	-7.64305478596649e-12	32	0	0	93	5314
WP3858	Toll-like Receptor Signaling	0.999999999992357	-7.64305478596649e-12	32	0	0	93	5314
WP3893	Development and heterogeneity of the ILC family	0.999999999992357	-7.64305478596649e-12	32	0	0	93	5314
WP2112	IL17 signaling pathway	0.999999999993202	-6.79767717052992e-12	31	0	0	93	5314
WP408	Oxidative Stress	0.999999999993202	-6.79767717052992e-12	31	0	0	93	5314
WP531	Mismatch repair	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP3875	ATR Signaling	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP3674	Tgif disruption of Shh signaling	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP3300	Dual hijack model of Vif in HIV infection	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP2942	DDX1 as a regulatory component of the Drosha microprocessor	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP3297	EV release from cardiac cells and their functional effects	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP696	Benzo(a)pyrene metabolism	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP288	NLR Proteins	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP561	Heme Biosynthesis	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP3585	Cytosine methylation	0.999999999993268	-6.73172387598395e-12	9	0	0	93	5314
WP3633	Caffeine and Theobromine metabolism	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP690	Polyol Pathway	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP1603	Nicotine Activity on Chromaffin Cells	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP2491	Diclofenac Metabolic Pathway	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP1133	Androgen receptor signaling pathway	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP2253	Pilocytic astrocytoma	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP897	Androgen receptor signaling pathway	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP2889	Oxytocin signaling	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP3302	eIF5A regulation in response to inhibition of the nuclear export system	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP521	Amino acid conjugation of benzoic acid	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP733	Serotonin Receptor 2 and STAT3 Signaling	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP1941	Peroxisomal beta-oxidation of tetracosanoyl-CoA	0.99999999999356	-6.43973561896931e-12	4	0	0	93	5314
WP2854	Gene regulatory network modelling somitogenesis	0.999999999993824	-6.1757749885711e-12	11	0	0	93	5314
WP3630	NAD metabolism, sirtuins and aging	0.999999999993824	-6.1757749885711e-12	11	0	0	93	5314
WP80	Nucleotide GPCRs	0.999999999993824	-6.1757749885711e-12	11	0	0	93	5314
WP3853	ERK Pathway in Huntington's Disease	0.999999999994034	-5.96558337139761e-12	14	0	0	93	5314
WP322	Osteoblast Signaling	0.999999999994034	-5.96558337139761e-12	14	0	0	93	5314
WP2436	Dopamine metabolism	0.999999999994034	-5.96558337139761e-12	14	0	0	93	5314
WP229	Irinotecan Pathway	0.999999999994034	-5.96558337139761e-12	14	0	0	93	5314
WP712	Estrogen signaling pathway	0.99999999999435	-5.65037755003043e-12	23	0	0	93	5314
WP3612	Photodynamic therapy-induced NFE2L2 (NRF2) survival signaling	0.99999999999435	-5.65037755003043e-12	23	0	0	93	5314
WP134	Pentose Phosphate Pathway	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP1272	Selenium Micronutrient Network	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP1310	Selenium Micronutrient Network	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP1995	Effects of Nitric Oxide	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP2805	RNA interference	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP2596	Gastric acid production	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP3595	mir-124 predicted interactions with cell cycle and differentiation	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP678	Arachidonate Epoxygenase / Epoxide Hydrolase	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP438	Non-homologous end joining	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP699	Aflatoxin B1 metabolism	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP528	Acetylcholine Synthesis	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP3924	Hfe effect on hepcidin production	0.99999999999519	-4.81017435722241e-12	7	0	0	93	5314
WP129	Matrix Metalloproteinases	0.999999999995954	-4.04606904831497e-12	30	0	0	93	5314
WP3844	PI3K-AKT-mTOR signaling pathway and therapeutic opportunities	0.999999999995954	-4.04606904831497e-12	30	0	0	93	5314
WP98	Prostaglandin Synthesis and Regulation	0.999999999995954	-4.04606904831497e-12	30	0	0	93	5314
WP2870	Extracellular vesicle-mediated signaling in recipient cells	0.999999999995954	-4.04606904831497e-12	30	0	0	93	5314
WP241	One Carbon Metabolism	0.999999999995954	-4.04606904831497e-12	30	0	0	93	5314
WP3408	Evolocumab Mechanism	0.999999999996549	-3.45098823039606e-12	3	0	0	93	5314
WP2846	Proprotein convertase subtilisin/kexin type 9 (PCSK9) mediated LDL receptor degradation	0.999999999996549	-3.45098823039606e-12	3	0	0	93	5314
WP2249	Metastatic brain tumor	0.999999999996731	-3.26876276449131e-12	28	0	0	93	5314
WP466	DNA Replication	0.999999999996885	-3.11467076288351e-12	42	0	0	93	5314
WP405	Eukaryotic Transcription Initiation	0.999999999996885	-3.11467076288351e-12	42	0	0	93	5314
WP49	IL-2 Signaling Pathway	0.999999999996885	-3.11467076288351e-12	42	0	0	93	5314
WP2636	Common Pathways Underlying Drug Addiction	0.999999999996885	-3.11467076288351e-12	42	0	0	93	5314
WP3601	Composition of Lipid Particles	0.999999999997608	-2.39217856179161e-12	10	0	0	93	5314
WP2113	Type III interferon signaling	0.999999999997608	-2.39217856179161e-12	10	0	0	93	5314
WP704	Methylation Pathways	0.999999999997608	-2.39217856179161e-12	10	0	0	93	5314
WP496	Steroid Biosynthesis	0.999999999997608	-2.39217856179161e-12	10	0	0	93	5314
WP1531	Vitamin D Metabolism	0.999999999997608	-2.39217856179161e-12	10	0	0	93	5314
WP2333	Trans-sulfuration pathway	0.999999999997608	-2.39217856179161e-12	10	0	0	93	5314
WP1311	Folic Acid Network	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP2816	Felbamate Metabolism	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP2646	Lidocaine metabolism	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP1438	Influenza A virus infection	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP2943	Hypoxia-mediated EMT and Stemness	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP2866	mir34a and TGIF2 in osteoclastogenesis	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP2901	Gonadotropin-releasing hormone (GnRH) signaling	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP2366	Butyrate-induced histone acetylation	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP1273	Folic Acid Network	0.999999999998785	-1.21505442426256e-12	2	0	0	93	5314
WP2868	TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer	0.999999999999138	-8.61905031049509e-13	5	0	0	93	5314
WP311	Synthesis and Degradation of Ketone Bodies	0.999999999999138	-8.61905031049509e-13	5	0	0	93	5314
WP2597	Secretion of Hydrochloric Acid in Parietal Cells	0.999999999999138	-8.61905031049509e-13	5	0	0	93	5314
WP2542	Sulindac Metabolic Pathway	0.999999999999138	-8.61905031049509e-13	5	0	0	93	5314
WP688	Catalytic cycle of mammalian Flavin-containing MonoOxygenases (FMOs)	0.999999999999138	-8.61905031049509e-13	5	0	0	93	5314
WP3596	miR-517 relationship with ARCN1 and USP1	0.999999999999138	-8.61905031049509e-13	5	0	0	93	5314
WP3670	Simplified Interaction Map Between LOXL4 and Oxidative Stress Pathway	0.999999999999689	-3.10550733095413e-13	21	0	0	93	5314
WP1602	Nicotine Activity on Dopaminergic Neurons	0.999999999999689	-3.10550733095413e-13	21	0	0	93	5314
WP691	Tamoxifen metabolism	0.999999999999689	-3.10550733095413e-13	21	0	0	93	5314
WP2533	Glycerophospholipid Biosynthetic Pathway	0.999999999999689	-3.10550733095413e-13	21	0	0	93	5314
WP2526	PDGF Pathway	0.999999999999847	-1.53131062331906e-13	38	0	0	93	5314
WP2029	Cell Differentiation - Index	0.999999999999847	-1.53131062331906e-13	38	0	0	93	5314
WP1742	TP53 Network	1	3.77628308873588e-16	20	0	0	93	5314
WP497	Urea cycle and metabolism of amino groups	1	3.77628308873588e-16	20	0	0	93	5314
WP516	Hypertrophy Model	1	3.77628308873588e-16	20	0	0	93	5314
WP391	Mitochondrial Gene Expression	1	3.77628308873588e-16	20	0	0	93	5314
WP732	Serotonin Receptor 2 and ELK-SRF/GATA4 signaling	1	3.77628308873588e-16	20	0	0	93	5314
WP127	IL-5 Signaling Pathway	1.00000000000006	6.18219362285022e-14	40	0	0	93	5314
WP1545	miRNAs involved in DNA damage response	1.00000000000015	1.47471575537224e-13	50	0	0	93	5314
WP2637	Structural Pathway of Interleukin 1 (IL-1)	1.00000000000015	1.47471575537224e-13	50	0	0	93	5314
WP58	Monoamine GPCRs	1.00000000000018	1.7917184808147e-13	33	0	0	93	5314
WP430	Statin Pathway	1.00000000000018	1.7917184808147e-13	33	0	0	93	5314
WP3676	BDNF-TrkB Signaling	1.00000000000018	1.7917184808147e-13	33	0	0	93	5314
WP2197	Endothelin Pathways	1.00000000000018	1.7917184808147e-13	33	0	0	93	5314
WP2363	Gastric Cancer Network 2	1.00000000000018	1.7917184808147e-13	33	0	0	93	5314
WP2586	Aryl Hydrocarbon Receptor	1.00000000000068	6.75526209124428e-13	48	0	0	93	5314
WP2849	Hematopoietic Stem Cell Differentiation	1.00000000000068	6.75526209124428e-13	48	0	0	93	5314
WP2848	Differentiation Pathway	1.00000000000068	6.75526209124428e-13	48	0	0	93	5314
WP1604	Codeine and Morphine Metabolism	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP136	Phase I biotransformations, non P450	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP237	Glucocorticoid &amp; Mineralcorticoid Metabolism	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP2338	miRNA Biogenesis	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP3655	Hypothetical Craniofacial Development Pathway	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP3407	FTO Obesity Variant Mechanism	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP3635	Insulin signalling in human adipocytes (diabetic condition)	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP3634	Insulin signalling in human adipocytes (normal condition)	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP2485	NAD Biosynthesis II (from tryptophan)	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP1589	Folate-Alcohol and Cancer Pathway	1.00000000000094	9.43559606470819e-13	8	0	0	93	5314
WP694	Arylamine metabolism	1.00000000000101	1.01187873207378e-12	6	0	0	93	5314
WP1600	Nicotine Metabolism	1.00000000000101	1.01187873207378e-12	6	0	0	93	5314
WP3891	Benzene metabolism	1.00000000000101	1.01187873207378e-12	6	0	0	93	5314
WP2332	Interleukin-11 Signaling Pathway	1.00000000000115	1.15352809266424e-12	44	0	0	93	5314
WP410	Diurnally Regulated Genes with Circadian Orthologs	1.00000000000136	1.35683645920433e-12	49	0	0	93	5314
WP2864	Apoptosis-related network due to altered Notch3 in ovarian cancer	1.00000000000147	1.47164487288829e-12	54	0	0	93	5314
WP1584	Type II diabetes mellitus	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP272	Blood Clotting Cascade	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP3645	NAD+ biosynthetic pathways	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP545	Complement Activation	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP100	Glutathione metabolism	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP167	Eicosanoid Synthesis	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP3872	Regulation of Apoptosis by Parathyroid Hormone-related Protein	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP3599	Transcription factor regulation in adipogenesis	1.00000000000177	1.76929375483767e-12	22	0	0	93	5314
WP3859	TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition	1.00000000000177	1.77204178972023e-12	18	0	0	93	5314
WP692	Sulfation Biotransformation Reaction	1.00000000000177	1.77204178972023e-12	18	0	0	93	5314
WP3413	NOTCH1 regulation of human endothelial cell calcification	1.00000000000177	1.77204178972023e-12	18	0	0	93	5314
WP3879	4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression	1.00000000000177	1.77204178972023e-12	18	0	0	93	5314
WP138	Androgen receptor signaling pathway	1.00000000000252	2.5194427189824e-12	90	0	0	93	5314
WP477	Cytoplasmic Ribosomal Proteins	1.00000000000252	2.5194427189824e-12	90	0	0	93	5314
WP2643	Nanoparticle-mediated activation of receptor signaling	1.00000000000265	2.64835533101615e-12	29	0	0	93	5314
WP422	MAPK Cascade	1.00000000000265	2.64835533101615e-12	29	0	0	93	5314
WP2037	Prolactin Signaling Pathway	1.00000000000284	2.83819550748413e-12	76	0	0	93	5314
WP465	Tryptophan metabolism	1.00000000000316	3.16162556976168e-12	46	0	0	93	5314
WP28	Selenium Metabolism and Selenoproteins	1.00000000000316	3.16162556976168e-12	46	0	0	93	5314
WP2291	Deregulation of Rab and Rab Effector Genes in Bladder Cancer	1.00000000000359	3.59322352360957e-12	16	0	0	93	5314
WP501	GPCRs, Class C Metabotropic glutamate, pheromone	1.00000000000359	3.59322352360957e-12	16	0	0	93	5314
WP2453	TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc)	1.00000000000359	3.59322352360957e-12	16	0	0	93	5314
WP3644	NAD+ metabolism	1.00000000000359	3.59322352360957e-12	16	0	0	93	5314
WP550	Biogenic Amine Synthesis	1.00000000000359	3.59322352360957e-12	16	0	0	93	5314
WP53	ID signaling pathway	1.00000000000359	3.59322352360957e-12	16	0	0	93	5314
WP3611	Photodynamic therapy-induced AP-1 survival signaling.	1.00000000000362	3.61867132699516e-12	51	0	0	93	5314
WP61	Notch Signaling Pathway	1.00000000000403	4.02744877832894e-12	62	0	0	93	5314
WP3584	MECP2 and Associated Rett Syndrome	1.00000000000403	4.02744877832894e-12	62	0	0	93	5314
WP2895	Differentiation of white and brown adipocyte	1.00000000000413	4.13276056370886e-12	25	0	0	93	5314
WP2865	IL1 and megakaryocytes in obesity	1.00000000000413	4.13276056370886e-12	25	0	0	93	5314
WP1528	Physiological and Pathological Hypertrophy  of the Heart	1.00000000000413	4.13276056370886e-12	25	0	0	93	5314
WP3668	Hypothesized Pathways in Pathogenesis of Cardiovascular Disease	1.00000000000413	4.13276056370886e-12	25	0	0	93	5314
WP205	IL-7 Signaling Pathway	1.00000000000413	4.13276056370886e-12	25	0	0	93	5314
WP3414	Initiation of transcription and translation elongation at the HIV-1 LTR	1.00000000000432	4.31821157254451e-12	37	0	0	93	5314
WP3529	Zinc homeostasis	1.00000000000432	4.31821157254451e-12	37	0	0	93	5314
WP2012	miRs in Muscle Cell Differentiation	1.0000000000045	4.49929762307814e-12	36	0	0	93	5314
WP3298	Melatonin metabolism and effects	1.0000000000045	4.49929762307814e-12	36	0	0	93	5314
WP325	Triacylglyceride Synthesis	1.00000000000486	4.85706154058096e-12	26	0	0	93	5314
WP26	Signal Transduction of S1P Receptor	1.00000000000486	4.85706154058096e-12	26	0	0	93	5314
WP530	Cytokines and Inflammatory Response	1.00000000000486	4.85706154058096e-12	26	0	0	93	5314
WP581	EPO Receptor Signaling	1.00000000000486	4.85706154058096e-12	26	0	0	93	5314
WP2431	Spinal Cord Injury	1.00000000000563	5.63015706200373e-12	119	0	0	93	5314
WP2018	RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway	1.00000000000571	5.71325062029178e-12	55	0	0	93	5314
WP3617	Photodynamic therapy-induced NF-kB survival signaling	1.000000000006	6.00417219588883e-12	35	0	0	93	5314
WP558	Complement and Coagulation Cascades	1.00000000000608	6.07629105809835e-12	60	0	0	93	5314
WP2035	Follicle Stimulating Hormone (FSH) signaling pathway	1.00000000000621	6.20854391756472e-12	27	0	0	93	5314
WP3845	Canonical  and Non-canonical Notch signaling	1.00000000000621	6.20854391756472e-12	27	0	0	93	5314
WP366	TGF-beta Signaling Pathway	1.00000000000667	6.67451073366616e-12	133	0	0	93	5314
WP560	TGF-beta Receptor Signaling	1.000000000007	6.99891280110236e-12	58	0	0	93	5314
WP3287	Overview of nanoparticle effects	1.00000000000732	7.31708776916866e-12	19	0	0	93	5314
WP247	Small Ligand GPCRs	1.00000000000732	7.31708776916866e-12	19	0	0	93	5314
WP1992	TarBasePathway	1.00000000000732	7.31708776916866e-12	19	0	0	93	5314
WP734	Serotonin Receptor 4/6/7 and NR3C Signaling	1.00000000000732	7.31708776916866e-12	19	0	0	93	5314
WP22	IL-9 Signaling Pathway	1.00000000000732	7.31708776916866e-12	19	0	0	93	5314
WP1	Statin Pathway	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP3191	TSLP Signaling Pathway	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP3627	Gut-Liver Indole Metabolism	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP2190	One carbon donor	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP661	Glucose Homeostasis	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP108	Selenium metabolism/Selenoproteins	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP188	Focal Adhesion	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP2536	Colchicine Metabolic Pathway	1.00000000000761	7.60854226844465e-12	1	0	0	93	5314
WP1601	Fluoropyrimidine Activity	1.000000000008	7.99834734897725e-12	34	0	0	93	5314
WP313	Signaling of Hepatocyte Growth Factor Receptor	1.000000000008	7.99834734897725e-12	34	0	0	93	5314
WP143	Fatty Acid Beta Oxidation	1.000000000008	7.99834734897725e-12	34	0	0	93	5314
WP400	p38 MAPK Signaling Pathway	1.000000000008	7.99834734897725e-12	34	0	0	93	5314
WP364	IL-6 signaling pathway	1.00000000000803	8.02668193401265e-12	43	0	0	93	5314
WP45	G1 to S cell cycle control	1.00000000000903	9.0347727562757e-12	68	0	0	93	5314
WP3624	Lung fibrosis	1.00000000000913	9.13480823732332e-12	63	0	0	93	5314
WP117	GPCRs, Other	1.00000000000944	9.44497204045823e-12	95	0	0	93	5314
WP2203	Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway	1.00000000000957	9.5701323887959e-12	47	0	0	93	5314
WP2435	Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis	1.00000000001178	1.17834610288149e-11	15	0	0	93	5314
WP206	Fatty Acid Omega Oxidation	1.00000000001178	1.17834610288149e-11	15	0	0	93	5314
WP3	Transcriptional activation by NRF2	1.00000000001178	1.17834610288149e-11	15	0	0	93	5314
WP197	Cholesterol Biosynthesis	1.00000000001178	1.17834610288149e-11	15	0	0	93	5314
WP2374	Oncostatin M Signaling Pathway	1.00000000001259	1.25889975357618e-11	66	0	0	93	5314
WP2406	Cardiac Progenitor Differentiation	1.00000000001301	1.30073893775426e-11	53	0	0	93	5314
WP1533	Vitamin B12 Metabolism	1.00000000001301	1.30073893775426e-11	53	0	0	93	5314
WP69	T-Cell antigen Receptor (TCR)  Signaling Pathway	1.00000000001326	1.32597840565344e-11	91	0	0	93	5314
WP2446	Retinoblastoma (RB) in Cancer	1.00000000001337	1.33692388140059e-11	88	0	0	93	5314
WP15	Selenium Micronutrient Network	1.00000000001591	1.59140400864168e-11	87	0	0	93	5314
